In this issue:
Cost effectiveness of second-line antihyperglycaemics
Metformin/sulphonylurea vs. diet and CV outcomes
Weight loss medication adherence
Weight loss required for risk factor modification
Metabolic sequelae of β-blocker therapy
Muscle mass and insulin resistance
Breastfeeding and maternal visceral adiposity
Breastfeeding reduces postpartum abnormal glucose tolerance
Interstitial vs. blood glucose during hypoglycaemia
Measuring glucose in tears
Please login below to download this issue (PDF)